HBM4003

Harbour BioMed gets FDA nod to begin clinical trial for HBM4003 in cancer
Pharmaceutical Business Review
Mon, 03/2/20 - 09:39 am
Harbor BioMed
FDA
HBM4003
clinical trials
solid tumors
cancer